PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy
10.1158/2159-8290.CD-12-0595
Saved in:
Main Authors: | Tan, J., Li, Z., Lee, P.L., Guan, P., Aau, M.Y., Lee, S.T., Feng, M., Lim, C.Z., Lee, E.Y.J., Wee, Z.N., Lim, Y.C., Karuturi, R.K.M., Yu, Q. |
---|---|
Other Authors: | GENOME INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/115861 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
An in vitro assay for the kinase activity of mTOR complex 2
by: Huang, J.
Published: (2016) -
mTOR, autophagy, and reprogramming
by: Tang, B.L
Published: (2020) -
B55β-Associated PP2A Complex Controls PDK1-Directed Myc signaling and modulates rapamycin sensitivity in colorectal cancer
by: Tan, J., et al.
Published: (2014) -
Judicious toggling of mTOR activity to combat insulin resistance and cancer: Current evidence and perspectives
by: Ong, P.S, et al.
Published: (2020) -
The Contribution of MYC and PLK1 Expression to Proliferative Capacity in Diffuse Large B-Cell Lymphoma
by: Ming Liang Oon, et al.
Published: (2020)